3 completed, 2 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Doheny Image Reading Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Image Biomarkers for Progression of AMD AMD | Withdrawn | Doheny Image Reading Center | 2021-01-01 | 2020-09-28 | ||
| Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery Bevacizumab Injection - Diabetic Macular Edema, Cataract | Not applicable | Withdrawn | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2020-01-01 | 2021-02-21 | |
| Testing Latest Version of NidekRS3000Adv RS3000Adv - Glaucoma | Completed | Doheny Image Reading Center | 100 | 2018-02-01 | 2018-07-09 | |
| The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates ranibizumab 0.3mg - Diabetic Macular Edema, Hard Lipid Exudates | Phase 1 / Phase 2 | Completed | South Coast Retina Center; Carson, McBeath, Boswell, Inc. | 25 | 2015-08-01 | 2021-07-08 |
| Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device Nidek MP-3 - Age-related Macular Degeneration (AMD) | Completed | Doheny Image Reading Center | 100 | 2015-06-01 | 2019-02-15 |
Cataract (1) · Glaucoma (1) · Macular Degeneration (1)
Bevacizumab (1) · Dexamethasone (1) · Ranibizumab (1)
United States (3)
Srinivas Sadda (1) · Srinivas Sadda, MD (1)